Skip to main content

Please select
your location below

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

By selecting the International view, you verify that you reside outside of the USA and you wish to view DiaSorin Molecular’s International Product Information. This material is intended for International (non-USA) site visitors only.

Pursuant to the Guidelines of the Ministry of Health dated 28/03/2013 related to health advertising concerning medical devices, in vitro diagnostic medical devices and medical-surgical devices, we hereby inform you that the information contained in this website and to which you are going to access is exclusively intended for professionaloperators.

Direct links

Mycoplasma pneumoniae Diagnostic Solution

Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide. Mycoplasma pneumoniae, just like Chlamydia pneumoniae and Legionella pneumophila infections, is often the source. The correct identification of the etiological agent causing CAP, therefore, can positively support clinical treatment decisions.

Diasorin aids the differential serological diagnosis of Mycoplasma pneumoniae by providing high-quality, fully automated, assays for IgG and IgM antibodies detection. These same tests can also help differentiate between acute and past infections.


LIAISON®Mycoplasma Pneumoniae IgG

Automated CLIA assay for the semi-quantitative determination of specific IgG antibodies to Mycoplasma pneumoniae in human serum or plasma samples.


LIAISON®Mycoplasma Pneumoniae IgM

Automated CLIA assay for the qualitative determination of specific IgM antibodies to Mycoplasma pneumoniae in human serum or plasma samples.

Indications for use


Detection of antibodies against Mycoplasma pneumoniae

Target patient

Adults and children

Use area

Pediatric medicine, general medicine, respiratory infections



The clinical manifestations of Mycoplasma pneumoniae infections are mainly limited to the respiratory tract, but the infection can also affect other organs. Furthermore, children are infected more often than adults.

Because the disease has an insidious onset with malaise, myalgia, sore throat or headache and increasing chest symptoms, detection of specific IgG and IgM antibodies against Mycoplasma pneumoniae is the primary diagnostic tool for acute Mycoplasma pneumoniae respiratory disease. 

To be used on

Designed for both specialty and routine tests, LIAISON® XL and LIAISON® XS immunoassay analyzers help your laboratory handle multiple patients and tests simultaneously. LIAISON® systems are trustworthy, intuitive and deliver automated continuous operation with minimal user intervention. The result is reduced turnaround time, optimal cost management and unmatched growth potential.

Fully Automated LIAISON® XL System - Diasorin


Designed for large laboratories. Fuse the benefits of high throughput and high sensitivity within a powerful and fully automated system that can seamlessly connect to facilitate Total Laboratory Automation. 

Discover more

More details about our diagnostic solutions

Login to Dialog for additional resources

Login to our repository for instructions for use and user manuals, assay information, protocols and much more.


Get in touch

If you need any information about our products, contact our specialists. 

Contact us

Need any help?

Get help with Diasorin products and services.

Ask for support

All the products in this family

Discover the range of specialty tests available

Discover more